Baxter International (MEX:BAX) Moat Score: 7/10 (As of Jun. 30, 2026)


MEX:BAX Baxter International Inc MEX:BAX
44 GF Score
Price MXN368.89
GF Value MXN576.45
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Baxter International Moat Score?

Baxter International MEX:BAX 44 Moat Score is 7 as of Jun. 30, 2026. GuruFocus rates MEX:BAX with a GF Score™ of 44/100 and a GF Value™ of MXN576.45 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Baxter International ranks better than 98.94% on this metric.

Baxter International has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Baxter International has Wide Moat: BAX has a wide moat due to its strong market leadership in healthcare products, valuable patents, and significant customer switching costs. It benefits from economies of scale and a robust distribution network, ensuring durable competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Baxter International might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Baxter International  (MEX:BAX) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Baxter International Moat Score Related Terms

MEX:BAX vs ALGN, SOLV, COO: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baxter International Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Moat Score distribution charts can be found below:

* The bar in red indicates where Baxter International's Moat Score falls into.


MEX:BAX
44GF Score
Baxter International Inc MEX:BAX
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Baxter International (MEX:BAX) has a Moat Score of 7 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Baxter International ranks #9 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Baxter International's Moat Score too high?
Baxter International's current Moat Score is 7. Based on the distribution chart, Baxter International ranks #9 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Baxter International has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Moat Score compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #9 out of 846 companies for Moat Score. This places Baxter International in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Baxter International's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (MEX:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is MXN576.45, compared to a current price of MXN368.89 — trading 36% below its estimated fair value. The current Moat Score is 7. Baxter International's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Baxter International (MEX:BAX), the current Moat Score is 7 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (MEX:BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of MXN368.89 is trading 36% below its estimated GF Value™ of MXN576.45. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for MEX:BAX:

  • Moat Score: 7
  • GF Value™: MXN576.45 vs. price of MXN368.89 (36% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the MEX:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
44GF Score

Get the complete analysis for MEX:BAX

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN368.89
Price
MXN576.45
GF Value